Int J Nurs Stud Adv
They dont include actual GLP-1 medications like semaglutide or tirzepatide, the only ingredients proven to work
Retatrutide is part of a new class of obesity medications sometimes nicknamed triple agonists. While popular drugs like Ozempic target one hormone pathway, GLP-1, and Zepbound activates two GLP-1 and GIP retatrutide targets three hormone receptors at once: GLP-1, GIP, and glucagon
Researchers combining retatrutide with recovery peptides should be especially attentive to nutritional adequacy and may benefit from stacking protocols that account for timing and injection scheduling
doi: 10.1111/dom.12605 222 KristensenSLRrthRJhundPSDochertyKFSattarNPreissDet al
Retrieved from Sato, K., Hara-Chikuma, M., Yasui, M., et al